Monocyte chemoattractant protein-1: a key mediator of angiotensin II-induced target organ damage in hypertensive heart disease?

被引：25

作者：

Zhuo, JL ^{[1
]}

机构：

[1] Henry Ford Hlth Sci Ctr, Div Hypertens & Vasc Res, Detroit, MI 48202 USA

来源：

JOURNAL OF HYPERTENSION | 2004年 / 22卷 / 03期

关键词：

D O I：

10.1097/00004872-200403000-00003

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：451 / 454

页数：4

共 27 条

[1] HYPERTENSION AND THE PATHOGENESIS OF ATHEROSCLEROSIS - OXIDATIVE STRESS AND THE MEDIATION OF ARTERIAL INFLAMMATORY RESPONSE - A NEW PERSPECTIVE [J].

ALEXANDER, RW .

HYPERTENSION, 1995, 25 (02) :155-161

[2] Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure [J].

Behr, TM ;

Wang, XK ;

Aiyar, N ;

Coatney, RW ;

Li, X ;

Koster, P ;

Angermann, CE ;

Ohlstein, E ;

Feuerstein, GZ ;

Winaver, J .

CIRCULATION, 2000, 102 (11) :1315-1322

[3] Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease [J].

Behr, TM ;

Willette, RN ;

Coatney, RW ;

Berova, M ;

Angermann, CE ;

Anderson, K ;

Sackner-Bernstein, JD ;

Barone, FC .

JOURNAL OF HYPERTENSION, 2004, 22 (03) :583-592

[4] Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats [J].

Capers, Q ;

Alexander, RW ;

Lou, PP ;

De Leon, H ;

Wilcox, JN ;

Ishizaka, N ;

Howard, AB ;

Taylor, WR .

HYPERTENSION, 1997, 30 (06) :1397-1402

[5] MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF 2 MONOCYTE CHEMOATTRACTANT PROTEIN-1 RECEPTORS REVEALS ALTERNATIVE SPLICING OF THE CARBOXYL-TERMINAL TAILS [J].

CHARO, IF ;

MYERS, SJ ;

HERMAN, A ;

FRANCI, C ;

CONNOLLY, AJ ;

COUGHLIN, SR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2752-2756

[6]

Chen XL, 1998, CIRC RES, V83, P952

[7] Are there benefits to specific antihypertensive drug therapy? [J].

Cushman, WC .

AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (11) :31S-35S

[8] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[9] Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells [J].

Funakoshi, Y ;

Ichiki, T ;

Shimokawa, H ;

Egashira, K ;

Takeda, K ;

Kaibuchi, K ;

Takeya, M ;

Yoshimura, T ;

Takeshita, A .

HYPERTENSION, 2001, 38 (01) :100-104

[10]

HernandezPresa M, 1997, CIRCULATION, V95, P1532

← 1 2 3 →